SLC22A5 and metabolic dysfunction-associated steatohepatitis: Moreover, similar results were observed in human MASLD tissues, where BBOX1 protein level was remarkably reduced in MASH patients’ tissues, while OCTN2 expression level remained relatively stable (Figure 4D).